Digital To fight rare diseases, win the data battle first Innovation is the key to evolution. In the pharmaceutical space, brilliant advancements have occurred with drugs with large population pools.
Partner Content Partner Content Invitation to SMI’s Orphan Drugs & Rare Diseases Conference ... SMi reports: Invitation from conference co-chair released for the 9th Annual Orphan Drugs & Rare Diseases conference, taking place in London this October
News Angelini Pharma's R&D chief heads for the exit Dr Rafal Kaminski's near five-year tenure as chief scientific officer of Italy's Angelini Pharma will come to an end in the next couple of weeks.
Sales & Marketing Sponsored Securing your ROI: Turning post-acquisition integration into... Join Forinnovia and Little Cube Consulting for a webinar on securing post-acquisition ROI.